Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Type of information:
(Q)SAR
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018
Report date:
2018

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
QSAR
GLP compliance:
no
Type of assay:
mammalian erythrocyte micronucleus test

Test material

Constituent 1
Reference substance name:
Cycloate
IUPAC Name:
Cycloate
Details on test material:
Cycloate

Results and discussion

Test results
Key result
Sex:
not specified
Genotoxicity:
negative
Remarks:
QSAR
Remarks on result:
not measured/tested
Remarks:
QSAR

Applicant's summary and conclusion

Conclusions:
ACD/Percepta genotoxicity (micronucleus in vivo) prediction is NEGATIVE, based on a positive prediction probability equal to 0.154.
In support to the above prediction, it is noted that ACD/Percepta did not identify relevant structural alerts for clastogenicity.
It is highlighted that a negative experimental data on micronucleus in vivo test (mouse/male and female/bone marrow) for the target compound Cycloate is available (CCRIS
Database).
Executive summary:

ACD/Percepta genotoxicity (micronucleus in vivo) prediction is NEGATIVE,